Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Difamilast ointment and skin barrier function in atopic dermatitis
jRCTs041240111Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of difamilast in atopic dermatitis (AD) (2 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Primary: Change in TEWL and SCH at forearm flexor at end of research. Started Nov 2024; status: completed.
02
Drugs
difamilast
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on jRCTs041240111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041240111.